MOVE
Movano Inc.NASDAQHealthcare$11.51-10.17%ClosedMarket Cap: $8.7M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-2502.32
P/S
18.12
EV/EBITDA
-0.23
DCF Value
$0.01
FCF Yield
-243.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
-424.9%
Operating Margin
-3580.4%
Net Margin
-6207.2%
ROE
35364.5%
ROA
-479.9%
ROIC
-1085.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $44.0K | -2147.7% | $-4.4M | $12.4M | $-20.60 | — |
| FY 2025 | $433.0K | -424.9% | $-15.5M | $-18.3M | $-21.79 | — |
| Q3 2025 | $80.0K | -250.0% | $-2.6M | $-4.0M | $-0.05 | — |
| Q2 2025 | $103.0K | -251.5% | $-3.3M | $-3.2M | $-0.41 | — |
| Q1 2025 | $206.0K | -211.7% | $-5.2M | $-5.2M | $-0.73 | — |
| Q4 2024 | $111.0K | -410.8% | $-4.7M | $-4.6M | $-0.08 | — |
| FY 2024 | $1.0M | -196.8% | $-24.2M | $-23.7M | $-0.39 | — |
| Q3 2024 | $50.0K | -1590.0% | $-7.4M | $-7.2M | $-0.11 | — |
| Q2 2024 | $0.00 | -Infinity% | $-6.4M | $-6.2M | $-0.09 | — |
| Q1 2024 | $852.0K | -42.6% | $-5.8M | $-5.7M | $-0.10 | — |
| Q4 2023 | $0.00 | -Infinity% | $-6.0M | $-6.0M | $-0.11 | — |
| FY 2023 | $0.00 | -Infinity% | $-29.7M | $-29.3M | $-0.63 | — |